Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -13,73k | 24,57k | Sale to Issuer | 1,79 | 2,02M | -0,68% |
| 2026-05-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 190,08 | Sale to Issuer | 1,92 | 3,91k | -2,47% |
| 2026-05-14 | Dr. Erick GamelinChief Development Officer | -404,00 | 775,68 | Sale to Issuer | 1,92 | 11,90k | -3,28% |
| 2026-05-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 353,28 | Sale to Issuer | 1,92 | 25,95k | -0,70% |
| 2026-05-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 940,80 | Sale to Issuer | 1,92 | 310,30k | -0,16% |
| 2026-05-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1,25k | 2,41k | Sale to Issuer | 1,92 | 1,99M | -0,06% |
| 2026-04-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 993,24 | Sale to Issuer | 1,78 | 25,51k | -2,14% |
| 2026-02-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -14,27k | 21,83k | Sale to Issuer | 1,53 | 1,99M | -0,71% |
| 2026-02-14 | Ms. Katharine PetersonVP of Finance & Accounting | -116,00 | 189,08 | Sale to Issuer | 1,63 | 4,01k | -2,81% |
| 2026-02-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -217,00 | 353,71 | Sale to Issuer | 1,63 | 24,17k | -0,89% |
| 2026-02-14 | Dr. Erick GamelinChief Development Officer | -471,00 | 767,73 | Sale to Issuer | 1,63 | 11,06k | -4,09% |
| 2026-02-14 | Dr. Eric J. DevroeCOO | -723,00 | 1,18k | Sale to Issuer | 1,63 | 68,33k | -1,05% |
| 2026-02-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1,30k | 2,12k | Sale to Issuer | 1,63 | 1,96M | -0,07% |
| 2026-02-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -579,00 | 943,77 | Sale to Issuer | 1,63 | 309,12k | -0,19% |
| 2026-01-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -659,00 | 1,30k | Sale to Issuer | 1,98 | 23,76k | -2,70% |
| 2026-01-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | 49,00k | 82,12k | Acquisto | 1,68 | 1,97M | 2,56% |
| 2026-01-14 | Dr. Adam D. LevyCFO & Principal Financial Officer | 8,83k | 15,00k | Acquisto | 1,70 | 13,75k | 179,73% |
| 2026-01-13 | Dr. Eric J. DevroeCOO | 10,00k | 17,22k | Acquisto | 1,72 | 66,96k | 17,56% |
| 2025-11-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19,90k | 45,78k | Sale to Issuer | 2,30 | 1,92M | -1,03% |
| 2025-11-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 221,76 | Sale to Issuer | 2,24 | 4,12k | -2,35% |
| 2025-11-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 412,16 | Sale to Issuer | 2,24 | 22,52k | -0,81% |
| 2025-11-14 | Dr. Erick GamelinChief Development Officer | -403,00 | 902,72 | Sale to Issuer | 2,24 | 10,28k | -3,77% |
| 2025-11-14 | Dr. Eric J. DevroeCOO | -613,00 | 1,37k | Sale to Issuer | 2,24 | 56,96k | -1,06% |
| 2025-11-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59,77k | 133,87k | Sale to Issuer | 2,24 | 1,89M | -3,07% |
| 2025-11-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 1,10k | Sale to Issuer | 2,24 | 308,03k | -0,16% |
| 2025-10-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 1,01k | Sale to Issuer | 1,81 | 20,18k | -2,69% |
| 2025-10-01 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -284,00 | 514,04 | Sale to Issuer | 1,81 | 20,73k | -1,35% |
| 2025-08-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19,91k | 26,27k | Sale to Issuer | 1,32 | 1,82M | -1,08% |
| 2025-08-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 137,61 | Sale to Issuer | 1,39 | 4,22k | -2,29% |
| 2025-08-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 255,76 | Sale to Issuer | 1,39 | 20,05k | -0,91% |
| 2025-08-14 | Dr. Erick GamelinChief Development Officer | -403,00 | 560,17 | Sale to Issuer | 1,39 | 9,43k | -4,10% |
| 2025-08-14 | Dr. Eric J. DevroeCOO | -613,00 | 852,07 | Sale to Issuer | 1,39 | 55,49k | -1,09% |
| 2025-08-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59,77k | 83,07k | Sale to Issuer | 1,39 | 1,80M | -3,21% |
| 2025-08-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 681,10 | Sale to Issuer | 1,39 | 306,85k | -0,16% |
| 2025-08-01 | Dr. Adam D. LevyCFO & Principal Financial Officer | -1,16k | 1,47k | Sale to Issuer | 1,26 | 4,91k | -19,15% |
| 2025-07-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 736,56 | Sale to Issuer | 1,32 | 20,34k | -2,67% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
